Remove Bioinformatics Remove Drug Research Remove Pharmaceutical Companies
article thumbnail

Accelerating Drug Discovery Through Repurposing

DrugBank

In Silico Drug Repurposing Advances in bioinformatics and systems biology have fueled the rise of repurposing of in silico drugs. CMap utilizes gene expression profiles to connect drugs, genes, and diseases, enabling researchers to identify potential repurposing candidates based on their transcriptional signatures.

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

Drug development: addressing complexity and success rates Drug development is a complex and expensive process, requiring multidisciplinary expertise and high-risk financial investments. The major hurdles that pharmaceutical companies face are long lead times, high costs and a low probability of success (PoS).